563 related articles for article (PubMed ID: 34466716)
1. Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries.
Zhao T; Wu W; Sui L; Huang Q; Nan Y; Liu J; Ai K
Bioact Mater; 2022 Jan; 7():47-72. PubMed ID: 34466716
[TBL] [Abstract][Full Text] [Related]
2. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review.
Venardos KM; Perkins A; Headrick J; Kaye DM
Curr Med Chem; 2007; 14(14):1539-49. PubMed ID: 17584062
[TBL] [Abstract][Full Text] [Related]
3. Oxidative and inflammatory biomarkers of ischemia and reperfusion injuries.
Halladin NL
Dan Med J; 2015 Apr; 62(4):B5054. PubMed ID: 25872540
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicine-Based Therapeutics for Myocardial Ischemic/Reperfusion Injury.
Li X; Ou W; Xie M; Yang J; Li Q; Li T
Adv Healthc Mater; 2023 Aug; 12(20):e2300161. PubMed ID: 36971662
[TBL] [Abstract][Full Text] [Related]
5. Biomaterials-mediated targeted therapeutics of myocardial ischemia-reperfusion injury.
Luo Q; Sun W; Li Z; Sun J; Xiao Y; Zhang J; Zhu C; Liu B; Ding J
Biomaterials; 2023 Dec; 303():122368. PubMed ID: 37977009
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen Peroxide-Responsive Nanoparticle Reduces Myocardial Ischemia/Reperfusion Injury.
Bae S; Park M; Kang C; Dilmen S; Kang TH; Kang DG; Ke Q; Lee SU; Lee D; Kang PM
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27930351
[TBL] [Abstract][Full Text] [Related]
7. Shenxian-Shengmai Oral Liquid Reduces Myocardial Oxidative Stress and Protects Myocardium from Ischemia-Reperfusion Injury.
Zhao Y; Zhang X; Luan J; Zhao B; An N; Sun N; Wang X; Zhao T; Sun Y; Fu ZD; Zhang Y; Zhang Y
Cell Physiol Biochem; 2018; 48(6):2503-2516. PubMed ID: 30121659
[TBL] [Abstract][Full Text] [Related]
8. The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion.
Raedschelders K; Ansley DM; Chen DD
Pharmacol Ther; 2012 Feb; 133(2):230-55. PubMed ID: 22138603
[TBL] [Abstract][Full Text] [Related]
9. The reduction of infarct size--forty years of research.
Ferreira R
Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotection of Tetrahedral DNA Nanostructures in Myocardial Ischemia-Reperfusion Injury.
Zhang M; Zhu J; Qin X; Zhou M; Zhang X; Gao Y; Zhang T; Xiao D; Cui W; Cai X
ACS Appl Mater Interfaces; 2019 Aug; 11(34):30631-30639. PubMed ID: 31382735
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of miR-34a-5p protected myocardial ischemia reperfusion injury-induced apoptosis and reactive oxygen species accumulation through regulation of Notch Receptor 1 signaling.
Wang Z; Wang Z; Wang T; Yuan J; Wang X; Zhang Z
Rev Cardiovasc Med; 2019 Sep; 20(3):187-197. PubMed ID: 31601093
[TBL] [Abstract][Full Text] [Related]
12. Molecular Characterization of Reactive Oxygen Species in Myocardial Ischemia-Reperfusion Injury.
Zhou T; Chuang CC; Zuo L
Biomed Res Int; 2015; 2015():864946. PubMed ID: 26509170
[TBL] [Abstract][Full Text] [Related]
13. Myocardial reperfusion injury and oxidative stress: Therapeutic opportunities.
González-Montero J; Brito R; Gajardo AI; Rodrigo R
World J Cardiol; 2018 Sep; 10(9):74-86. PubMed ID: 30344955
[TBL] [Abstract][Full Text] [Related]
14. Carthamin Yellow Protects the Heart Against Ischemia/Reperfusion Injury With Reduced Reactive Oxygen Species Release and Inflammatory Response.
Lu QY; Ma JQ; Duan YY; Sun Y; Yu S; Li B; Zhang GM
J Cardiovasc Pharmacol; 2019 Sep; 74(3):228-234. PubMed ID: 31356540
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation of tissue plasminogen activator in pH-sensitive self-assembled antioxidant nanoparticles for ischemic stroke treatment - Synergistic effect of thrombolysis and antioxidant.
Mei T; Kim A; Vong LB; Marushima A; Puentes S; Matsumaru Y; Matsumura A; Nagasaki Y
Biomaterials; 2019 Sep; 215():119209. PubMed ID: 31181394
[TBL] [Abstract][Full Text] [Related]
16. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species-mediated cardiac-reperfusion injury: Mechanisms and therapies.
Bagheri F; Khori V; Alizadeh AM; Khalighfard S; Khodayari S; Khodayari H
Life Sci; 2016 Nov; 165():43-55. PubMed ID: 27667751
[TBL] [Abstract][Full Text] [Related]
18. Ginsenoside Rg3-loaded, reactive oxygen species-responsive polymeric nanoparticles for alleviating myocardial ischemia-reperfusion injury.
Li L; Wang Y; Guo R; Li S; Ni J; Gao S; Gao X; Mao J; Zhu Y; Wu P; Wang H; Kong D; Zhang H; Zhu M; Fan G
J Control Release; 2020 Jan; 317():259-272. PubMed ID: 31783047
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial ROS in myocardial ischemia reperfusion and remodeling.
Bugger H; Pfeil K
Biochim Biophys Acta Mol Basis Dis; 2020 Jul; 1866(7):165768. PubMed ID: 32173461
[TBL] [Abstract][Full Text] [Related]
20. Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice.
Braunersreuther V; Pellieux C; Pelli G; Burger F; Steffens S; Montessuit C; Weber C; Proudfoot A; Mach F; Arnaud C
J Mol Cell Cardiol; 2010 Apr; 48(4):789-98. PubMed ID: 19665464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
